Search results - 6 results
Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
than the national rate (57%), and the overall cancer incidence of 5.5/100 000 is below the national French level. The EVE database will be useful to assess trends in cervical morbidity over time and to ...
Early effects of human papillomavirus vaccination in Belgium.
vaccination has been reimbursed in Belgium since 2007 for girls (12-15 years), extended to girls up to 18 years in 2008. This study assesses the trend of HPV 16/18 infections in women less than 25 years of age ...
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
regression was used to assess changes in CC incidence and mortality trends. RESULTS: The Polish programme adheres partially to EuG in terms of policy and organisation. Only a limited set of performance ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
vaccinate 44% of all girls aged between 12-15 years. However, the trend was decreasing over the last 10 months. By the current reimbursement policy, we can expect that maximum half of the target population ...
Trends of cervical cancer mortality in the member states of the European Union.
we analyse cervical cancer mortality trends in the 27 member states since 1970 and, subsequently, try to explain how screening and other factors have driven changes. METHODS: Data on number of deaths ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
cervical cancer mortality trend analysis Abstract: OBJECTIVE: To correct cervical cancer mortality rates for death cause certification problems in Belgium and to describe the corrected trends (1954-1997) ...